Cargando…
The Role of Antiphospholipid Antibodies in COVID-19
PURPOSE OF THE REVIEW: Elevated levels of anti-phospholipid (aPL) antibodies are the most important criterion in the diagnosis of anti-phospholipid syndrome (APS) and are usually responsible for promoting the risk of thrombotic complications. Now, in the course of the global coronavirus disease 2019...
Autores principales: | Stelzer, Maximilian, Henes, Jörg, Saur, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278370/ https://www.ncbi.nlm.nih.gov/pubmed/34259944 http://dx.doi.org/10.1007/s11926-021-01041-7 |
Ejemplares similares
-
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
por: Foret, Thomas, et al.
Publicado: (2021) -
Epidemiology of Antiphospholipid Syndrome in the General Population
por: Dabit, Jesse Y., et al.
Publicado: (2022) -
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome
por: Stoots, Sarah Abramson, et al.
Publicado: (2019) -
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update
por: Erkan, Doruk, et al.
Publicado: (2021) -
Cautious interpretation of antiphospholipid antibodies in COVID-19
por: Mehta, Sudhir, et al.
Publicado: (2020)